The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature, and other conventional methods are ineffective. GlobalData uses proprietary data and analytics to provide a comprehensive report on the topical absorbable hemostats market in Chile. Buy the latest report here.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Topical absorbable hemostats are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon. TAH products are often plant or gelatin based and act as mechanical barriers and/or help with vasoconstriction and a platform for platelet aggregation to slow the flow of blood and give the patient's body time to form a clot. Flowable hemostats or fibrin sealants are tracked under the tissue sealants and adhesives market. Hemostats include active hemostats (thrombin-based hemostats), and combination and passive hemostats (oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, polysaccharide-based hemostats, collagen-based hemostats). Oxidized regenerated cellulose-based hemostats are poly anions that contain polyanhydroglucuronic acid as a functional unit to aid in the platelet adhesion and aggregation process resulting in coagulation. Gelatin is a protein developed by denaturing the collagen and polymerizing with nitrogen to produce a porous scaffold. Polysaccharide based hemostats are purified plant derived starch. Collagen is a protein derived from animal source.
The topical absorbable hemostats market in Chile can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size topical absorbable hemostats in Chile, buy the report here.